Rajesh Behl, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Karyopharm
    Topic:
    Speaker
    Date added:
    01/10/2025
    Date updated:
    01/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Topic:
    Speaker
    Date added:
    01/10/2025
    Date updated:
    01/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Speaker
    Date added:
    01/10/2025
    Date updated:
    01/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Consulting
    Date added:
    01/10/2025
    Date updated:
    01/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Topic:
    Consulting
    Date added:
    01/10/2025
    Date updated:
    01/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen Biotech
    Topic:
    Consulting
    Date added:
    01/10/2025
    Date updated:
    01/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Jazz Pharmaceuticals
    Topic:
    Consulting
    Date added:
    01/10/2025
    Date updated:
    01/10/2025
Return to Northern California Hematology Oncology Conference: A Tumor Board Case-Based Approach to the Latest Breakthroughs